Thus, these data suggest that in NSCLC cell lines that have poor ASO-mediated KRAS knockdown, more ASO is being trafficked on the late endosome-lysosome pathway for degradation or exocytosis, which may be an important mechanism that prevents productive uptake of ASOs. Here, KRAS is linked to non-small cell lung carcinoma.